Norisoboldine suppresses VEGF-induced endothelial cell migration via the cAMP-PKA-NF-κB/Notch1 pathway

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lu, Qian ^a   Tong, Bei ^a   Luo, Yubin ^a   Sha, Li ^b   Chou, Guixin ^c   Wang, Zhengtao ^c   Xia, Yufeng ^a   Dai, Yue ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; NORISOBOLDINE; NOTCH1 RECEPTOR; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CHINESE MEDICINE; COMPLEX FORMATION; DOWN REGULATION; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MODULATION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

ALKALOIDS; BLOTTING, WESTERN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOPRECIPITATION; NF-KAPPA B; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892589192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081220     Document Type: Article

References (45)

1. Szekanecz Z, Besenyei T, Szentpétery A, Koch AE (2010) Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol 22: 299-306.
2. Szekanecz Z, Besenyei T, Paragh G, Koch AE (2009) Angiogenesis in rheumatoid arthritis. Autoimmunity 42: 563-573.
3. Lainer-Carr D, Brahn E (2007) Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol 3: 434-442.
4. Hofer E, Schweighofer B (2007) Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. Thromb Haemost 97: 355-363.
5. Muñoz-Chápuli R, Quesada AR, Angel Medina M (2004) Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61: 2224-2243.
6. Welf ES, Haugh JM (2011) Signaling pathways that control cell migration: models and analysis. Wiley Interdiscip Rev Syst Biol Med 3: 231-240.
7. Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405.
8. Somanath PR, Razorenova OV, Chen J, Byzova TV (2006) Akt1 in endothelial cell and angiogenesis. Cell Cycle 5: 512-518.
9. Konoplyannikov M, Haider KH, Lai VK, Ahmed RP, Jiang S, et al. (2013) Activation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair. Stem Cells Dev 22: 204-215.
10. Howe AK (2004) Regulation of actin-based cell migration by cAMP/PKA. Biochim Biophys Acta 1692: 159-174.
11. Lu Q, Lu S, Gao X, Luo Y, Tong B, et al. (2012) Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype. Exp Biol Med (Maywood) 237: 919-932.
12. Wei ZF, Jiao XL, Wang T, Lu Q, Xia YF, et al. (2013) Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression. Acta Pharmacol Sin 34: 403-413.
13. Chou GX, Norio N, Ma CM, Wang ZT, Masao H (2005) Isoquinoline alkaloids from Lindera aggregate. Chin J Nat Med 5: 272-275.
14. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, et al. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152: 1445-1452.
15. Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, et al. (2008) TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 111: 4997-5007.
16. Nakatsu MN, Sainson RC, Pérez-del-Pulgar S, Aoto JN, Aitkenhead M, et al. (2003) VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab Invest 83: 1873-1885.
17. Bello G, Cailotto F, Hanriot D, Kolopp-Sarda MN, Latger-Cannard V, et al. (2008) C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway. Atherosclerosis 200: 286-293.
18. Luo Y, Liu M, Dai Y, Yao X, Xia Y, et al. (2010) Norisoboldine inhibits the production of pro-inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 cells by down-regulating the activation of MAPKs but not NF-κB. Inflammation 33: 389-397.
19. Xing D, Gong K, Feng W, Nozell SE, Chen YF, et al. (2011) O-GlcNAc modification of NFκB p65 inhibits TNF-α-induced inflammatory mediator expression in rat aortic smooth muscle cells. PLoS One 6: e24021.
20. Li C, Lu N, Qi Q, Li F, Ling Y, et al. (2011) Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway. Biochem Pharmacol 82: 1873-1883.
21. Sastri M, Barraclough DM, Carmichael PT, Taylor SS (2005) A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci U S A 102: 349-354.
22. Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, et al. (2007) Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood 110: 3517-3525.
23. Park HB, Yang JH, Chung KH (2011) Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells. Korean J Hematol 46: 265-273.
24. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791.
25. Kim SH, Ha YM, Moon KM, Choi YJ, Park YJ, et al. (2013) Anti-melanogenic effect of (Z)-5-(2, 4-dihydroxybenzylidene) thiazolidine-2, 4-dione, a novel tyrosinase inhibitor. Arch Pharm Res. In Press.
26. Kim C, Vigil D, Anand G, Taylor SS (2006) Structure and dynamics of PKA signaling proteins. Eur J Cell Biol 85: 651-654.
27. Baker MA, Hetherington L, Aitken RJ (2006) Identification of SRC as a key PKA-stimulated tyrosine kinase involved in the capacitation-associated hyperactivation of murine spermatozoa. J Cell Sci 119: 3182-3192.
28. Zhang D, Ouyang J, Wang N, Zhang Y, Bie J, et al. (2010) Promotion of PDGF-induced endothelial cell migration by phosphorylated VASP depends on PKA anchoring via AKAP. Mol Cell Biochem 335: 1-11.
29. Bir SC, Xiong Y, Kevil CG, Luo J (2012) Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc Res 95: 7-18.
30. Janssen-Heininger YM, Poynter ME, Baeuerle PA (2000) Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327.
31. Zhuang LL, Jin R, Zhu LH, Xu HG, Li Y, et al. (2013) Promoter Characterization and Role of cAMP/PKA/CREB in the Basal Transcription of the Mouse ORMDL3 Gene. PLoS One 8: e60630.
32. Van Waes C (2007) Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 1076-1082.
33. Ichiki T (2005) Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both? Arterioscler Thromb Vasc Biol 26: 449-455.
34. Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1: a000034.
35. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424.
36. Khalil RA (2013) Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease. Pharmaceuticals (Basel) 6: 407-439.
37. Giorgi C, Agnoletto C, Baldini C, Bononi A, Bonora M, et al. (2010) Redox control of protein kinase C: cell-and disease-specific aspects. Antioxid Redox Signal 13: 1051-1085.
38. Reyland ME (2009) Protein kinase C isoforms: Multi-functional regulators of cell life and death. Front Biosci 14: 2386-2399.
39. Basu A, Sivaprasad U (2007) Protein kinase Cepsilon makes the life and death decision. Cell Signal 19: 1633-1642.
40. Kim C, Vigil D, Anand G, Taylor SS (2006) Structure and dynamics of PKA signaling proteins. Eur J Cell Biol 85: 651-654.
41. Engen JR, Wales TE, Hochrein JM, Meyn MA 3rd, Banu Ozkan S, et al. (2008) Structure and dynamic regulation of Src-family kinases. Cell Mol Life Sci 65: 3058-3073.
42. Lieu C, Kopetz S (2010) The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy. Clin Colorectal Cancer 9: 89-94.
43. Kwiatkowski AV, Gertler FB, Loureiro JJ (2003) Function and regulation of Ena/VASP proteins. Trends Cell Biol 13: 386-392.
44. Jutooru I, Chadalapaka G, Lei P, Safe S (2010) Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J Biol Chem 285: 25332-25344.
45. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, et al. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279: 51163-51171.